tiprankstipranks
Mcpherson'S Limited (AU:MCP)
ASX:MCP
Want to see AU:MCP full AI Analyst Report?

Mcpherson'S Limited (MCP) AI Stock Analysis

6 Followers

Top Page

AU:MCP

Mcpherson'S Limited

(Sydney:MCP)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$0.14
▼(-41.67% Downside)
Action:ReiteratedDate:04/25/26
The score is primarily held down by ongoing profitability and cash flow weakness, alongside a technically bearish downtrend. Recent revenue growth and improved leverage provide some support but are not yet translating into sustainable earnings or stronger price momentum.
Positive Factors
Revenue Growth Trend
Sustained double-digit top-line growth across recent periods indicates strengthening demand and distribution traction for core health, beauty and wellness brands. Durable revenue expansion improves scale economics, supports reinvestment in marketing and sourcing, and underpins longer-term margin recovery if operating efficiency follows.
Negative Factors
Persistent Profitability Losses
Ongoing negative operating and net margins indicate structural inefficiencies or cost base misalignment versus revenue. Until the company converts higher gross margins into positive EBIT/EBITDA, it cannot sustainably generate owner returns. Persistent losses constrain reinvestment and raise dependency on external funding for growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Trend
Sustained double-digit top-line growth across recent periods indicates strengthening demand and distribution traction for core health, beauty and wellness brands. Durable revenue expansion improves scale economics, supports reinvestment in marketing and sourcing, and underpins longer-term margin recovery if operating efficiency follows.
Read all positive factors

Mcpherson'S Limited (MCP) vs. iShares MSCI Australia ETF (EWA)

Mcpherson'S Limited Business Overview & Revenue Model

Company Description
McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort pr...
How the Company Makes Money
McPherson's makes money primarily by selling consumer health, beauty and wellness products into wholesale and retail channels. Revenue is generated from (1) sales of branded products the company owns or manages (brand development, marketing and ca...

Mcpherson'S Limited Financial Statement Overview

Summary
Strong recent revenue growth and improved gross margin are outweighed by persistent losses (negative net margin) and weak operating profitability (negative EBIT/EBITDA). Cash flow is a key risk, with free cash flow down sharply and low cash conversion.
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue134.24M138.99M144.63M155.23M214.00M200.50M
Gross Profit62.31M80.45M35.09M47.77M90.80M87.48M
EBITDA-6.83M-6.99M-4.92M3.10M7.44M5.98M
Net Income-16.42M-15.04M-15.99M-5.06M333.00K-5.37M
Balance Sheet
Total Assets116.49M117.21M146.90M190.06M215.76M199.59M
Cash, Cash Equivalents and Short-Term Investments12.74M9.48M24.77M7.03M13.14M7.35M
Total Debt7.07M7.30M19.85M25.45M29.38M20.93M
Total Liabilities45.97M44.23M57.26M80.61M94.95M84.96M
Stockholders Equity70.52M72.98M89.64M109.45M120.81M114.62M
Cash Flow
Free Cash Flow6.08M1.57M9.64M4.70M16.32M168.00K
Operating Cash Flow6.31M2.21M12.34M6.55M18.57M2.69M
Investing Cash Flow-1.85M-3.62M16.29M-1.85M-2.25M-31.80M
Financing Cash Flow-3.54M-13.91M-10.90M-10.91M-10.59M29.42M

Mcpherson'S Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.24
Price Trends
50DMA
0.18
Negative
100DMA
0.20
Negative
200DMA
0.24
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
37.54
Neutral
STOCH
21.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.18, and above the 200-day MA of 0.24, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 37.54 is Neutral, neither overbought nor oversold. The STOCH value of 21.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
AU$30.38M21.2514.06%1.54%-18.76%504.55%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
AU$36.17M157.840.80%4.92%-82.38%
45
Neutral
AU$18.28M-0.262542.90%-47.12%-18.92%
45
Neutral
AU$21.18M-3.00-16.89%41.14%93.28%
44
Neutral
AU$5.63M-5.68-10.69%-23.30%78.42%
43
Neutral
AU$21.59M-3.77-22.89%19.92%11.14%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:MCP
Mcpherson'S Limited
0.15
-0.13
-46.43%
AU:PTL
Pental Ltd.
0.03
-0.03
-43.10%
AU:ABY
Adore Beauty Group Ltd.
0.39
-0.35
-47.26%
AU:SKN
Skin Elements Limited
AU:CCX
City Chic Collective Limited
0.06
-0.03
-31.25%
AU:S66
Star Combo Pharma Ltd.
0.23
0.12
104.55%

Mcpherson'S Limited Corporate Events

McPherson’s Updates Market on Progress of On‑Market Share Buy-Back
Apr 23, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its ongoing on‑market share buy-back, covering ordinary fully paid shares under code MCP. The update, dated 24 April 2026, reports that the company had bough...
McPherson’s Cuts FY26 EBITDA Growth Outlook but Sticks With Share Buy-Back
Apr 23, 2026
McPherson’s Limited has warned that its earlier expectation of moderate year-on-year growth in underlying FY26 EBITDA will not be met, as sales under its stabilising new operating model have been weaker than anticipated and suppliers have in...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Apr 19, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The latest filing confirms that a total of 2,641,130 shares had been repurchased b...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Apr 8, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its on-market share buy-back of ordinary fully paid shares. The company reports that, as of the latest daily update dated 9 April 2026, it has bought back a total ...
McPherson’s Updates Market on Ongoing On‑Market Share Buy‑Back
Apr 7, 2026
McPherson’s Limited, an ASX-listed company trading under the code MCP, has ordinary fully paid shares as its primary listed security, but the announcement does not specify the company’s core operating industry or main products and serv...
McPherson’s Updates Market on Ongoing On-Market Share Buy-Back
Apr 1, 2026
McPherson’s Limited, an Australian-listed consumer products company trading under the code MCP, has ordinary fully paid shares that are the subject of an on-market buy-back program. The company uses this capital management mechanism to adjus...
McPherson’s Expands On-Market Buy-Back With Fresh Daily Purchases
Mar 30, 2026
McPherson’s Limited has continued its on-market share buy-back program, reporting a cumulative 1,440,317 ordinary fully paid shares repurchased prior to the latest trading day. On the previous day alone, the company bought back an additional...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Mar 29, 2026
McPherson’s Limited has continued its on-market share buy-back program, reporting that a total of 1,350,317 ordinary fully paid shares had been repurchased before the previous trading day. The company disclosed that it bought back a further ...
Microequities Exits Substantial Holder Position in McPherson’s Limited
Mar 26, 2026
Microequities Asset Management has lodged a notice with the ASX advising that it has ceased to be a substantial holder in McPherson’s Limited. The filing indicates that Microequities’ voting interest in McPherson’s has fallen bel...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Mar 25, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its on-market share buy-back of ordinary fully paid shares under code MCP. The company continues to execute its approved buy-back program, indicating active capita...
McPherson’s Updates Market on Progress of On‑Market Share Buy‑Back
Mar 18, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its on-market share buy-back program for ordinary fully paid shares. The company reported that a cumulative 480,317 shares had been repurchased before the previous...
McPherson’s details flexible on-market share buy-back activity
Mar 16, 2026
McPherson’s Limited has lodged a daily notification with the ASX outlining activity under its on-market share buy-back program for its ordinary fully paid shares, identified under code MCP, as at 17 March 2026. The company currently has 143,...
McPherson’s Launches Flexible On‑Market Share Buy‑Back
Mar 12, 2026
McPherson’s Limited has lodged a daily notification with the ASX confirming it is conducting an on‑market share buy‑back of its ordinary fully paid shares. The buy‑back applies to a total on‑issue capital of 143,949,1...
McPherson’s Unveils $2 Million On-Market Share Buy-Back as Part of Capital Management Drive
Feb 25, 2026
McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products under brands such as Manicare, Swisspers and Dr. LeWinn’s, targets consumers through pharmacy, grocery, health food and online retail channels. The c...
McPherson’s Sets Webcast to Present 1H26 Financial Results
Feb 25, 2026
McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products built around brands such as Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health, targets consumers via pharmacy, grocery, health food and...
McPherson’s trims costs, lifts cash as new operating model beds down despite 1H loss
Feb 25, 2026
McPherson’s reported revenue from continuing operations of $66.0 million for the half year to 31 December 2025, a 6.7% decline, but maintained largely stable core brand sales at $61.9 million as Manicare and Swisspers delivered solid growth ...
McPherson’s Announces Departure of Director Jane McKellar and Discloses Final Shareholding
Feb 1, 2026
McPherson’s Limited has announced the cessation of director Jane Matisse McKellar from the company’s board effective 31 January 2026, in accordance with ASX listing rule disclosure requirements. At the time of her departure, McKellar h...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 25, 2026